VBP15-004: Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active- controlled Study with Double-Blind Extension to Assess the Efficacy and Safety of Vamorolone in Ambulant Boys with Duchenne Muscular Dystrophy

Project: Research project

Project Details

StatusActive
Effective start/end date8/13/188/31/20

Funding

  • Reveragen Biopharma, Inc.
  • Reveragen Biopharma, Inc.